Prevalence of hypertension and associated factors in workers from Plaza Minorista Jose Maria Villa, Medellin.

Prevalencia de la hipertensión arterial y factores asociados en trabajadores de la Plaza Minorista José María Villa, Medellín

Published 2016-06-30


https://doi.org/10.30554/archmed.16.1.1172.2016
Open | Download
PDF (Spanish) FLIP HTML (Spanish)
Issue
Vol. 16 No. 1
Section
Research Articles
How to Cite
Cardona Arias, J. A., Vergara-Arango, M., & Caro-Londoño, A. M. (2016). Prevalence of hypertension and associated factors in workers from Plaza Minorista Jose Maria Villa, Medellin. Archivos De Medicina (Manizales), 16(1), 43-52. https://doi.org/10.30554/archmed.16.1.1172.2016
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX
DOI

https://doi.org/10.30554/archmed.16.1.1172.2016
Dimensions
PlumX

How to Cite

Cardona Arias, J. A., Vergara-Arango, M., & Caro-Londoño, A. M. (2016). Prevalence of hypertension and associated factors in workers from Plaza Minorista Jose Maria Villa, Medellin. Archivos De Medicina (Manizales), 16(1), 43-52. https://doi.org/10.30554/archmed.16.1.1172.2016

Download Citation

license
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Jaiberth Antonio Cardona Arias
Melissa Vergara-Arango
Anyi Melissa Caro-Londoño
Show authors biography

Most read articles by the same author(s)

Objective: to determine the prevalence of hypertension in workers from Plaza Minorista and its distribution by sociodemographic and cardiovascular conditions, Medellin 2015. Methods: cross-sectional study on 399 individuals, general medical evaluation, socio-demographic survey, anthropometry, ASSIST (Alcohol, Smoking and Substance Involvement Screening Test) and IPAQ (International Physical Activity Questionnaire) were done. The overall prevalence of hypertension and other cardiovascular risks such as obesity, overweight, sedentary lifestyle and consumption of psychoactive was determined. The specific prevalence of hypertension was estimated according to demographic and cardiovascular risk variables. The confusion was quantified with logistic regression. Results: the prevalence of hypertension was 35.1%; overweight 40.1%, visceral obesity 59.9%, sedentary lifestyle 57.6%, smoking 22.8%, alcohol consumption 33.3% and family history of hypertension 36.8%, of diabetes 30.1% and dyslipidemia 23.8%. Hypertension presented association with age, sex, personal history of diabetes, visceral obesity, educational level and BMI. Conclusion: a high prevalence of hypertension was found, men and obese were the subgroups with higher occurrence; this is useful for guiding research and medical efforts in similar groups.

Article visits | PDF visits

Downloads

Download data is not yet available.
  1. Sociedad Colombiana de Cardiología y Cirugía Cardiovascular.
  2. Guías colombianas para el diagnóstico
  3. y tratamiento de la hipertensión arterial. Rev Col
  4. Cardiol 2007;13(supp1):188-214.
  5. Lewington S, Clarke R, Qizibash N, Peto R, Collins
  6. R. Prospective Studies Collaboration age specific
  7. relevance of usual blood pressure to vascular
  8. mortality: a meta-analysis of individual date for
  9. one million adults in 61 prospective studies. Lancet
  10. ; 360(9349):1903-13.
  11. Miura K, Daviglus M, Dyer A, Liu K, Garside D,
  12. Stainler J, et al. Relationship of blood pressures
  13. to 25-years mortality due to coronary heart disease,
  14. cardiovascular diseases and all causes in
  15. young adult men: the Chicago Heart Association
  16. Detection Project in Industry. Arch Intern Med
  17. ;161(12):1501-8.
  18. Coutibn G, Borges J, Batista R, Feal P. El control
  19. de la hipertensión arterial puede incrementar la
  20. esperanza de vida, verificación de una hipótesis.
  21. Rev Cubana Med 2001; 40(2):103-8.
  22. World Health Organization (WHO). The atlas of heart
  23. disease and stroke. Ginebra: WHO; 2015.
  24. Segura L, Agusti R, Parodi J. Factores de riesgo de
  25. las enfermedades cardiovasculares en el Perú.
  26. Rev Peru Cardiol 2006;32(2):82-128.
  27. Lee D, Chiu M, Manuel D, Tu K, Wang X, Austin P,
  28. et al. Trends in risk factors for cardiovascular
  29. disease in Canada: temporal, socio-demographic
  30. and geographic factors. CMAJ 2009; 181(3-4):
  31. -66.
  32. Alayon A, Ariza S, Baena K, Lambis L, Martinez
  33. L, Benitez L. Búsqueda activa y evaluación de
  34. factores de riesgo cardiovascular en adultos
  35. jóvenes, Cartagena de Indias, 2007. Biomedica
  36. ; 30(2):238-44.
  37. Wolf K, Cooper R, Banegas J, Giampaoli S, Hense
  38. H, Joffres M, et al. Hypertension prevalence and
  39. blood pressure levels in 6 European countries,
  40. Canada, and the Unites States. JAMA 2003;
  41. (18):2363-9.
  42. Banegas J. Epidemiologia de la hipertensión arterial
  43. en España. Situación actual y perspectivas.
  44. Hipertensión 2005; 22(9):353-62.
  45. Wu L, He Y, Jiang B, Sun D, Wang J, Liu M, et al.
  46. Trends in prevalence, Awareness, Treatment and
  47. Control of Hypertension during 2001-2010 in an
  48. Urban Elderly Population of China. PLoS One
  49. ; 10(8):e0132814.
  50. Ministerio de la Protección Social, República de
  51. Colombia. Encuesta Nacional de Salud. Bogotá
  52. DC: Ministerio de la Protección Social, República de
  53. Colombia; 2007.
  54. Cardona-Arias JA, Arroyave-Martínez EY. Prevalencia
  55. de hipertensión arterial en universitarios,
  56. Medellín. Curare 2014; 1(1):17-26.
  57. Bautista L, Vera L, Villamil L, Silva S, Peña I, Luna
  58. L. Factores de riesgo asociados con la prevalencia
  59. de hipertensión arterial en adultos de
  60. Bucaramanga, Colombia. Salud Pública Mex. 2002;
  61. (55):399-405.
  62. Akpan EE, Ekrikpo UE, Udo AI, Bassey BE. ������Prevalence
  63. of Hypertension in Akwa Ibom State, South-
  64. South Nigeria: Rural versus Urban Communities
  65. Study. Int J Hypertens 2015; 2015:975819.
  66. Adediran O. S., Okpara I. C., Adeniyi O. S., Jimoh
  67. A. K. Hypertension prevalence in an urban and
  68. rural area of Nigeria. J Med Medical Sci 2013;
  69. (4):149–54.
  70. Ulasi I, Ijoma C, Onodugo O. A community-based
  71. study of hypertension and cardio-metabolic syndrome
  72. in semi-urban and rural communities in
  73. Nigeria. BMC Health Serv Res. 2010; 10:71.
  74. Organización Panamericana de la Salud (OPS), Organización
  75. Mundial de la Salud (OMS). La prueba
  76. de detección de consumo de alcohol, Tabaco y
  77. sustancias (ASSIT). Manual para uso en la atención
  78. primaria. Ginebra: OMS; 2011.
  79. Craig C, Marshall A, Sjöström M, Bauman A, Booth
  80. M, et al. International physical activity questionnaire:
  81. -country reliability and validity. Med Sci
  82. Sports Exerc 2003; 35(8):1381-95.
  83. Organización Mundial de la Salud (OMS). Estadísticas
  84. sanitarias mundiales 2005. Ginebra: OMS; 2005.
  85. Moreno M. Definición y clasificación de la obesidad.
  86. Rev Med Clin CONDES 2012;23(2):124-8.
  87. Alberti R, Eckel S, Grundy P, Zimmet J, Cleeman
  88. K, Donato J, et al. Harmonizing the metabolic
  89. syndrome: a joint interim statement of the International
  90. Diabetes Federation Task Force on Epidemiology
  91. and Prevention; National Heart, Lung
  92. and Blood Institute; American Heart Association;
  93. World Heart Federation; International Atherosclerosis
  94. Society; and International Association for the
  95. Study of Obesity. Circulation 2009; 120(16):1640-5.
  96. Sánchez M. Índice cintura/cadera, obesidad y
  97. estimación del riesgo cardiovascular en un centro
  98. de salud de Málaga. Med de Familia 2001; 2(3):208-
  100. Redon J, Lurbe E. Hipertensión arterial y obesidad.
  101. Med Clin 2007; 129(17):655-7
  102. Faloia E, Giacchetti G, Mantero F. Obesity and
  103. hypertension. J Endocrinol Invest 2000; 23(1):54-62.
  104. Lurbe E, Álvarez V, Liao Y, Tacons J, Cooper R,
  105. Cremades B, et al. The impact of obesity and
  106. body fat distribution on ambulatory blood pressure
  107. in children and adolescents. Am J Hypertens
  108. ;11(4):418-24.
  109. Kroke A, Bergmann M, Klipstein-Grobusch K, Boeing
  110. H. Obesity, body fat distribution and body build:
  111. their relation to blood pressure and prevalence of
  112. hypertension. Int J Obes Relat Metb Disord 1998;
  113. :1062-70.
  114. Parikh NI, Pencina MJ, Wang TJ, Lanier KJ, Fox CS,
  115. D’Agostino RB, et al. Increasing trends in incidence
  116. of overweight and obesity over 5 decades. Am J
  117. Med 2007; 120(3):242-50.
  118. Day C. Metabolic syndrome, or what you will:
  119. definitions and epidemiology. Diab Vasc Dis Res
  120. ; 4(1):32-8.
  121. Okosun IS, Prewitt TE, Cooper RS. Abdominal
  122. obesity in the United States: prevalence and attributable
  123. risk of hypertension. J Hum Hypertens
  124. ; 13(7):425-30.
  125. Navarro J, Redon J, Cea-Calvo L, Lozano JV, Fernández-
  126. Pérez C, Bonet A, et al. Metabolic syndrome,
  127. organ damage and cardiovascular disease in trea
  128. ted hypertensive patients. The ERIC-HTA study.
  129. Blood Press 2007; 16(1):20-7.
  130. Kolanowski J. Obesity and hypertension: from
  131. pathophysiology to treatment. Int J Obes Relat
  132. Metab Disord 1999; 23(Suppl 1):42-6.
  133. De Simone G, Devereux RB, Roman MJ. Relation
  134. of obesity and gender to left ventricular hypertrophy
  135. in normotensive and hypertensive adults.
  136. Hypertension 1994; 23(5):600-6.

Information

Google Scholar Profile

Author Guidelines